Neoadjuvant chemotherapy scheme customized by BRCA1 levels in Her-2 negative primary breast cancer patients: a randomized clinical trial. Bernaq study
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI